352 related articles for article (PubMed ID: 19564889)
1. Chemotherapy-associated renal dysfunction.
Sahni V; Choudhury D; Ahmed Z
Nat Rev Nephrol; 2009 Aug; 5(8):450-62. PubMed ID: 19564889
[TBL] [Abstract][Full Text] [Related]
2. [Nephrotoxicity induced by chemotherapy].
Di Vito R; Sirolli V; Amoroso L; Bonomini M
G Ital Nefrol; 2011; 28(3):296-304. PubMed ID: 21626498
[TBL] [Abstract][Full Text] [Related]
3. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer.
Merouani A; Shpall EJ; Jones RB; Archer PG; Schrier RW
Kidney Int; 1996 Sep; 50(3):1026-31. PubMed ID: 8872980
[TBL] [Abstract][Full Text] [Related]
4. The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis.
He L; Li J; Zhan J; Yi F; Fan X; Wei Y; Zhang W
Cancer Chemother Pharmacol; 2019 Mar; 83(3):561-571. PubMed ID: 30610366
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.
Launay-Vacher V; Oudard S; Janus N; Gligorov J; Pourrat X; Rixe O; Morere JF; Beuzeboc P; Deray G;
Cancer; 2007 Sep; 110(6):1376-84. PubMed ID: 17634949
[TBL] [Abstract][Full Text] [Related]
6. Influence of baseline renal function and dose reduction of nephrotoxic chemotherapeutic agents on the outcome of metastatic urothelial carcinoma: a retrospective study.
Maru S; Abe T; Shinohara N; Sazawa A; Maruyama S; Harabayashi T; Suzuki S; Nonomura K
Int J Urol; 2012 Feb; 19(2):110-6. PubMed ID: 22126100
[TBL] [Abstract][Full Text] [Related]
7. Delayed neoplastic and renal complications in women receiving long-term chemotherapy for recurrent ovarian cancer.
Muggia F; Cannon T; Safra T; Curtin J
J Natl Cancer Inst; 2011 Jan; 103(2):160-1. PubMed ID: 21115880
[No Abstract] [Full Text] [Related]
8. [Anticancer drugs management in renal insufficiency patients].
Zimmer-Rapuch S; Lheureux S; Brocard F; Janus N; Launay-Vacher V; Ray-Coquard I
Bull Cancer; 2012 Mar; 99(3):323-31. PubMed ID: 22123599
[TBL] [Abstract][Full Text] [Related]
9. Onconephrology: the latest frontier in the war against kidney disease.
Salahudeen AK; Bonventre JV
J Am Soc Nephrol; 2013 Jan; 24(1):26-30. PubMed ID: 23138480
[TBL] [Abstract][Full Text] [Related]
10. Cystatin C more accurately detects mildly impaired renal function than creatinine in children receiving treatment for malignancy.
Blufpand HN; Tromp J; Abbink FC; Stoffel-Wagner B; Bouman AA; Schouten-van Meeteren AY; van Wijk JA; Kaspers GJ; Bökenkamp A
Pediatr Blood Cancer; 2011 Aug; 57(2):262-7. PubMed ID: 21462304
[TBL] [Abstract][Full Text] [Related]
11. Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.
Funakoshi Y; Fujiwara Y; Kiyota N; Mukohara T; Shimada T; Toyoda M; Imamura Y; Chayahara N; Tomioka H; Umezu M; Otsuki N; Nibu K; Minami H
Cancer Chemother Pharmacol; 2016 Feb; 77(2):281-8. PubMed ID: 26791871
[TBL] [Abstract][Full Text] [Related]
12. Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron.
Childs AM; Coates AS; Cox KM; Mainwaring PN
Ann Oncol; 1994 Jan; 5(1):98. PubMed ID: 8172803
[No Abstract] [Full Text] [Related]
13. Importance of monitoring renal function in patients with cancer.
Aapro M; Launay-Vacher V
Cancer Treat Rev; 2012 May; 38(3):235-40. PubMed ID: 21605937
[TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer.
Jagieła J; Bartnicki P; Rysz J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924827
[TBL] [Abstract][Full Text] [Related]
15. Diversity in renal function monitoring and dose modifications during treatment for childhood cancer: a call for standardization.
Blufpand HN; Hes N; Bökenkamp A; van de Wetering MD; Kaspers GJ
Pediatr Blood Cancer; 2014 Feb; 61(2):337-44. PubMed ID: 23907811
[TBL] [Abstract][Full Text] [Related]
16. Tubulointerstitial injury associated with chemotherapeutic agents.
Shirali AC; Perazella MA
Adv Chronic Kidney Dis; 2014 Jan; 21(1):56-63. PubMed ID: 24359987
[TBL] [Abstract][Full Text] [Related]
17. [Dose optimization of anticancer drugs in the elderly].
Imamura CK
Gan To Kagaku Ryoho; 2015 Jan; 42(1):21-5. PubMed ID: 25596677
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin nephrotoxicity in a patient with a single kidney.
Udeani GO; Singh K; Mullane MR; Lad TE
Ann Pharmacother; 1996; 30(7-8):782-6. PubMed ID: 8826561
[TBL] [Abstract][Full Text] [Related]
19. Massive oxidative haemolysis and renal failure caused by high dose vitamin C.
Rees MJ; Strach MC; Burbury K; Phillips KA
Med J Aust; 2018 Sep; 209(6):248-249. PubMed ID: 30208815
[No Abstract] [Full Text] [Related]
20. [Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].
Losonczy G; Máthé C; Müller V; Szondy K; Moldvay J
Magy Onkol; 2010 Dec; 54(4):289-96. PubMed ID: 21163759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
